BlackRock Investment Management’s Perspective Therapeutics CATX Stock Holding History

BlackRock Investment Management’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-983	Closed	-$9K	–	4047
2016 Q1	$9K	Hold	983	–	–	﹤0.01%	3643
2015 Q4	$9K	Buy	983 +65	+7%	+$810	﹤0.01%	3707
2015 Q3	$13K	Hold	918	–	–	﹤0.01%	3572
2015 Q2	$14K	Hold	918	–	–	﹤0.01%	3577
2015 Q1	$14K	Hold	918	–	–	﹤0.01%	3531
2014 Q4	$13K	Hold	918	–	–	﹤0.01%	3578
2014 Q3	$16K	Buy	918 +33	+4%	+$817	﹤0.01%	3473
2014 Q2	$28K	Buy	+885	New	+$22.2K	﹤0.01%	3323

Other funds holding CATX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CAG

Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

BlackRock Investment Management's CATX Position: Q2 2016 in Review

BlackRock Investment Management sold out of Perspective Therapeutics (CATX) in Q2 2016, closing a stake of 983 shares — an estimated $9K sold.

BlackRock Investment Management first reported a position in CATX in Q2 2014 and held it in 8 quarters. The position peaked at $28K in Q2 2014. 27 funds tracked by Wall St. Rank hold CATX as of Q2 2016.

BlackRock Investment Management reported no remaining Perspective Therapeutics position as of Q2 2016 after selling out during the quarter.
BlackRock Investment Management sold 983 Perspective Therapeutics shares in Q2 2016, an estimated $9K.
BlackRock Investment Management first reported a position in Perspective Therapeutics in Q2 2014 and held it in 8 quarters.
BlackRock Investment Management's Perspective Therapeutics position peaked at $28K in Q2 2014.
27 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.